WebbMHRA Updates: COVID-19 vaccines and drugs - updates for March 2024 updated 24/03/23. Letters both pharmacy recalls submitted to healthcare professionals in February2024 updated 24/03/23. Pholcodine-containing cough and colder medicament: withdrawal from UK markets as a preemptive measu re added 14/03/23 Webb14 mars 2024 · The MHRA advises that pholcodine-containing cough and cold medicines are being removed from the UK market as a precautionary measure. Dr Alison Cave, …
MHRA Products Substance
Following a scientific review by the MHRA on pholcodine-containing medicines, which are licensed to treat dry cough in adults and children over 6 years old, it has been found that there is evidence of an increased risk of the very rare event of anaphylaxis (a sudden, severe and life-threatening allergic … Visa mer For more information or, medical enquiries, please contact the respective companies below: The Boots Company PLC Boots Customer … Visa mer Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and … Visa mer Stop supplying the above products immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process. This recall applies to all batches currently within shelf-life for the … Visa mer WebbMHRA/CHM advice (March 2008 and February 2009) Over-the-counter cough and cold medicines for children. Children under 6 years should not be given over-the-counter … autosbynelson va
Over-the-counter cough and cold medicines for children
Webb15 mars 2024 · Cough and cold medicines containing pholcodine are being withdrawn from the UK market after an investigation into the risk of allergic reactions by the Medicines and Healthcare Products Regulatory Agency (MHRA). 1 WebbThe potential for cross-reactivity between pholcodine and NMBAs was added to the product information for pholcodine-containing medicines in January 2024. The MHRA review considered the cumulative safety information, including the results from the recently completed ALPHO study,1 which showed that use of pholcodine Webb15 mars 2024 · The MHRA review considered the cumulative safety information, including the results from the recently completed ALPHO study, which showed that use of pholcodine during the 12 months preceding anaesthesia was significantly associated with an increased risk of perianaesthetic anaphylaxis to NMBAs (adjusted odds ratio = 4.2; … autoschade jan kok